The short answer
Melanoma comes back at or near the scar, in transit between the scar and the nearest nodes, or in nodes and distant organs. NCI says it may return where it started or elsewhere, such as the lungs or liver. The node surgery question has changed, and the treatment list now runs on immunotherapy and BRAF-directed targeted therapy.
NCI says recurrent melanoma may return where it started or elsewhere in the body, such as the lungs or liver.
In-transit disease means melanoma deposits in the skin between the scar and the nearest node basin.
Routine complete node dissection after a positive sentinel node is no longer automatic: in the trial NCI reports it did not improve distant metastasis-free survival and lymphedema occurred in 24.1% versus 6.3%.
NCI's list for unresectable stage III, stage IV and recurrent melanoma runs on immunotherapy and on BRAF and MEK targeted drugs; the list is a catalogue rather than a ranking.
On this page
Choose how you want to read this
The whole article, with every detail and caution.
The three places melanoma comes back
NCI says recurrent melanoma may return where it started, or elsewhere in the body, such as the lungs or liver.
In practice teams talk about three patterns. A return at or near the scar. In-transit disease, meaning deposits in the skin and tissue between the scar and the nearest node basin. And spread to lymph nodes or distant organs.
NCI counts in-transit spread as regional disease when it stages melanoma.
Your own eyes are part of the surveillance
NCI's diagnostic list starts with a skin exam, where a doctor or nurse checks the skin for areas that look wrong in color, size, shape or texture.
You can partly do that same exam yourself between visits. Ask to be shown how.
Ask what you are feeling for along the path between the scar and the nodes.
The node question that changed
If a sentinel node contains melanoma, removing all the nodes in that area used to be routine. The evidence moved.
NCI reports a trial where complete node dissection did not improve distant metastasis-free survival. Lymphedema occurred in 24.1% of the dissection group, against 6.3% of the group under observation.
NCI describes ultrasound surveillance of the regional nodes as an option for people with hidden node disease. Ask whether that applies to you.
What treatment looks like now
For stage III melanoma that cannot be removed, stage IV, and recurrent melanoma, NCI lists immunotherapy with pembrolizumab, nivolumab, ipilimumab, interleukin-2, nivolumab with relatlimab, or atezolizumab. A catalogue is not a running order. What your team proposes will turn on your BRAF result, whether you already had adjuvant immunotherapy, how fast the disease is moving, and what your body can tolerate.
Targeted therapy is the other track. NCI names dabrafenib, trametinib, vemurafenib, cobimetinib, encorafenib and binimetinib.
For melanoma in a limb, isolated limb perfusion and injected talimogene laherparepvec both appear in NCI's summaries.
Questions for the melanoma team
- Is this at the scar, in transit, in the nodes, or further away?
- Do I need a biopsy of the new spot to confirm it is melanoma?
- Has my tumor been tested for a BRAF change, and does that open the targeted track?
- What is my LDH level, and what does it tell you here?
- I had adjuvant pembrolizumab or nivolumab already. Does that change which drug you would use now?
- These spots are on my leg. Would injected therapy or limb perfusion be considered?
- How often will you check my skin and nodes from here?
When another melanoma specialist should look
Melanoma treatment has changed fast. NCI itself notes that new drugs and combinations are arriving quickly, and suggests considering a clinical trial at progression.
That is a good reason to get a second opinion, especially at a center that runs melanoma trials.
When to get help sooner
- Call 911 or go to an emergency department if you pass black or tarry stool, you have a seizure, sudden weakness or numbness on one side, sudden trouble speaking or seeing, or the worst headache of your life with vomiting. These can be signs that cancer has reached the brain. Go too for severe breathlessness or chest pain. Do not drive yourself.
- Call your care team right away if you are on pembrolizumab or nivolumab and have diarrhea or more bowel movements than usual, blood or mucus in your stool, severe belly pain, a new cough or breathlessness, yellow eyes or dark urine, or a rash that is blistering or peeling, or new confusion, sleepiness, a stiff neck or balance problems. Do not wait for a certain number of stools. These drugs can turn the immune system against healthy organs. Getting assessed early matters, because your team has to sort an immune side effect from an infection before deciding what to do; steroids are one of the treatments they may use, not an automatic one. Use the 24-hour number on your immunotherapy card, and carry the card. Call right away for a temperature of 100.4°F (38°C) or higher too. Also call right away for unusual tiredness, dizziness, feeling cold all the time, or headaches that will not go away. These can point to a hormone gland affected by immunotherapy.
- Call your care team within a day or two if a new lump appears at or near your old scar, you feel a firm nodule under the skin between the scar and the nearest nodes, or a lymph node stays swollen.
Related pages
See also: Local vs Distant Recurrence, Biomarker Testing, Clinical Trial vs Standard Treatment, and Questions to Ask Your Doctor.
Where this comes from
Common questions
What does in-transit disease mean?
Deposits in the skin and the tissue between the original scar and the nearest lymph node basin. Ask what you are feeling for along that path.
If a sentinel node is positive, do all the nodes come out?
Not automatically any more. NCI reports a trial in which complete node dissection did not improve distant metastasis-free survival, while lymphedema occurred in 24.1% of the dissection group against 6.3% of the group under observation. NCI describes ultrasound surveillance of the regional nodes as an option instead.
Which drugs are on the list now?
For stage III melanoma that cannot be removed, stage IV, and recurrent melanoma, NCI lists immunotherapy with pembrolizumab, nivolumab, ipilimumab, interleukin-2, nivolumab with relatlimab, or atezolizumab, and targeted therapy with dabrafenib, trametinib, vemurafenib, cobimetinib, encorafenib and binimetinib. That is a catalogue rather than a running order. Which of these applies to you depends on your BRAF result, whether you had adjuvant treatment already, how fast the disease is moving and your other health.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Turn this topic into questions for your next appointment.
Talk with a trained specialist or navigator
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-08-11 what this meansLast updated: 2026-09-30Next planned review: 2028-07-30
Review details and limits
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Words to know
Tap any term to see what it means.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.